Vicore is collaborating with University University London to conduct a stage 1 trial that is slated to do this fall. Meanwhile, some experts have revisited the theory that the AT2 receptor can be targeted to treat hypertension. The Japanese company Mitsubishi Tanabe Pharma, located in Osaka, is rolling out an agonist called MP-157. This compound is currently being tested in a stage 1 trial in European countries for hypertension.Wilson of the University of Texas Southwestern Medical Center; Sandy Markowitz of Case Western Reserve Howard and University Hughes Medical Institute; and Christoph Lengauer of Sanofi-Aventis. Under agreements between your Johns Hopkins University, Genzyme Molecular Oncology, Novartis, Wyeth, Amgen, Horizon and Glaxo-Smith-Kline, Yun, Velculescu, Rajagopalan, Pagliarini, Lengauer, Kinzler, Vogelstein, and Papadopoulos have entitlement to a share of the royalties and licensing charges received by the University on cell lines referred to in this information release, some of which are the subject matter of patent applications. The Velculescu and University, Kinzler and Vogelstein also own stock in Genzyme, which is at the mercy of certain limitations under University policy.




COMPANY PROFILE | CUSTOMER SERVICE | PRODUCTS
LEADING PRODUCTS | CATALOGUE | TO CONTACT US

info@uniformetecnic.com